Open access chemical and clinical probes to support drug discovery

2009 ◽  
Vol 5 (7) ◽  
pp. 436-440 ◽  
Author(s):  
Aled M Edwards ◽  
Chas Bountra ◽  
David J Kerr ◽  
Timothy M Willson
Keyword(s):  
Author(s):  
Jane F Armstrong ◽  
Elena Faccenda ◽  
Simon D Harding ◽  
Adam J Pawson ◽  
Christopher Southan ◽  
...  

Abstract The IUPHAR/BPS Guide to PHARMACOLOGY (www.guidetopharmacology.org) is an open-access, expert-curated database of molecular interactions between ligands and their targets. We describe significant updates made over the seven releases during the last two years. The database is notably enhanced through the continued linking of relevant pharmacology with key immunological data types as part of the IUPHAR Guide to IMMUNOPHARMACOLOGY (www.guidetoimmunopharmacology.org) and by a major new extension, the IUPHAR/MMV Guide to Malaria PHARMACOLOGY (www.guidetomalariapharmacology.org). The latter has been constructed in partnership with the Medicines for Malaria Venture, an organization dedicated to identifying, developing and delivering new antimalarial therapies that are both effective and affordable. This is in response to the global challenge of over 200 million cases of malaria and 400 000 deaths worldwide, with the majority in the WHO Africa Region. It provides new pharmacological content, including molecular targets in the malaria parasite, interaction data for ligands with antimalarial activity, and establishes curation of data from screening assays, used routinely in antimalarial drug discovery, against the whole organism. A dedicated portal has been developed to provide quick and focused access to these new data.


2002 ◽  
Vol 37 (9) ◽  
pp. 889-896 ◽  
Author(s):  
Larry M. Mallis ◽  
Ani B. Sarkahian ◽  
John M. Kulishoff ◽  
William L. Watts

2016 ◽  
Vol 11 (3) ◽  
pp. 321-332 ◽  
Author(s):  
Zeeshaan Arshad ◽  
James Smith ◽  
Mackenna Roberts ◽  
Wen Hwa Lee ◽  
Ben Davies ◽  
...  
Keyword(s):  

2017 ◽  
Vol 61 (9) ◽  
Author(s):  
Sandra Duffy ◽  
Melissa L. Sykes ◽  
Amy J. Jones ◽  
Todd B. Shelper ◽  
Moana Simpson ◽  
...  

ABSTRACT Open-access drug discovery provides a substantial resource for diseases primarily affecting the poor and disadvantaged. The open-access Pathogen Box collection is comprised of compounds with demonstrated biological activity against specific pathogenic organisms. The supply of this resource by the Medicines for Malaria Venture has the potential to provide new chemical starting points for a number of tropical and neglected diseases, through repurposing of these compounds for use in drug discovery campaigns for these additional pathogens. We tested the Pathogen Box against kinetoplastid parasites and malaria life cycle stages in vitro. Consequently, chemical starting points for malaria, human African trypanosomiasis, Chagas disease, and leishmaniasis drug discovery efforts have been identified. Inclusive of this in vitro biological evaluation, outcomes from extensive literature reviews and database searches are provided. This information encompasses commercial availability, literature reference citations, other aliases and ChEMBL number with associated biological activity, where available. The release of this new data for the Pathogen Box collection into the public domain will aid the open-source model of drug discovery. Importantly, this will provide novel chemical starting points for drug discovery and target identification in tropical disease research.


2010 ◽  
Vol 11 (7) ◽  
pp. 764-778 ◽  
Author(s):  
Anuradha Roy ◽  
Peter R. McDonald ◽  
Sitta Sittampalam ◽  
Rathnam Chaguturu

2018 ◽  
Author(s):  
Joseph D. Romano ◽  
Victor Nwankwo ◽  
Nicholas P. Tatonetti

AbstractMotivationVenom peptides comprise one of the richest sources of bioactive compounds available for drug discovery. However, venom data and knowledge are fragmentary and poorly structured, and fail to capitalize on the important characteristics of venoms that make them so interesting to the biomedical community.ResultsWe present VenomKB v2.0, a new open-access resource for knowledge representation and retrieval of venom bioactivities, sequences, structures, and classifications. VenomKB provides a complete infrastructure for computational toxinology, with a focus on drug discovery and effects that venoms have on the human body. VenomKB is accompanied by a suite of tools for programmatic access, and, in this article, we highlight scenarios demonstrating its usefulness and novel contributions to toxinology, pharmacology, and informatics.AvailabilityVenomKB can be accessed online at http://venomkb.org/, and the code can be found at https://github.com/tatonetti-lab/venomkb/. All code and data are available under open-source and open-access licenses.


2018 ◽  
Vol 2 ◽  
pp. 239821281879927
Author(s):  
Ann J. Hunter ◽  
Wen H. Lee ◽  
Chas Bountra

The pressures on the pharmaceutical industry have incentivised a number of new collaborative models of research and development which can be categorised as open innovation. Examples of the different types of models employed are discussed and some, but not all, of these have been used to promote research and drug discovery for central nervous system disorders. Some are completely open access, while others have some intellectual property restrictions. Going forward, more ways of promoting open innovation and the sharing of best practice, especially in the neurosciences, will stimulate research and hopefully accelerate new medicines development.


2016 ◽  
Vol 122 ◽  
pp. 1-8 ◽  
Author(s):  
Junling Gao ◽  
Scott S. Ceglia ◽  
Michael D. Jones ◽  
Jennifer Simeone ◽  
John Van Antwerp ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document